COMMUNIQUÉS West-GlobeNewswire

Mesa Labs Announces First Quarter Results
10/08/2026
LAKEWOOD, Colo., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or the “Company”), a global leader in the design and manufacture of life science tools and critical quality control [...]
Olema Oncology Reports Second Quarter 2026 Financial and Operating Results
10/08/2026
Completed enrollment in the pivotal Phase 3 OPERA-01 trial; top-line data are now expected in the first quarter of 2027 Presented initial Phase 1 clinical data for OP-3136 at the 2026 ASCO Annual Meeting Announced a [...]
HRC Technology Solutions LLC Achieves SOC 1 Type 2 and SOC 2 Type 2 Compliance, Reinforcing Secure, AI-Driven Revenue Cycle Management
10/08/2026
SOUTHLAKE, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- HRC Technology Solutions LLC today announced it has achieved SOC 1 Type 2 and SOC 2 Type 2 compliance, independently assessed by ControlCase as its Qualified Security [...]
MAPS Responds to Report of Progress for MDMA-assisted therapy for PTSD with FDA
10/08/2026
The reported resubmission of the New Drug Application will initiate a new evaluation of the treatment’s safety and efficacy for potential FDA approval Recently updated FDA guidance, Psychedelic Drugs: Considerations for [...]
AIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward Planned Phase 3 Development in Pancreatic Cancer
10/08/2026
Completed Enrollment and Ampligen Dosing in Metastatic Pancreatic Cancer Phase 2 Trial, Positioning Company for Key Clinical Milestones Through Early 2027 Pancreatic Cancer Remains Strategic Priority as AIM Advances [...]
Kura Oncology Announces Publication in Blood Highlighting Ziftomenib’s Differentiated Binding Profile and Preclinical Activity
10/08/2026
– Publication details the discovery and preclinical characterization of ziftomenib, including its potency, selectivity, and mechanism of action – – Findings demonstrate differentiated menin binding and activity against [...]
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Second Quarter 2026 Financial Results on August 14, 2026
10/08/2026
FREDERICK, Md., Aug. 10, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions today announced it will report results for the second [...]
Capricor Therapeutics to Report Second Quarter 2026 Financial Results and Provide Recent Corporate Update on August 13
10/08/2026
– Company to Host Conference Call on August 13, 2026, at 4:30 p.m. ET – SAN DIEGO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and [...]
Wave Life Sciences Announces Completion of Redomiciliation to Delaware
10/08/2026
CAMBRIDGE, Mass., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (NASDAQ: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health (“ [...]
Baird Medical and Alpmed Enter Strategic Partnership to Advance Irreversible Electroporation (IRE) Technology Globally
10/08/2026
Agreement combines Baird Medical's clinical, regulatory, and global commercialization expertise with Alpmed's leadership in IRE technology Collaboration will advance technology development, global regulatory approvals, [...]
Autonomix Medical Congratulates Co-Founder & Chief Medical Officer Dr. Robert Schwartz on Receiving Prestigious 2026 Cardiovascular Tech Forum Lifetime Achievement Award
10/08/2026
Recognition honors one of the medical technology industry's most influential innovators, whose career has helped shape modern cardiovascular care THE WOODLANDS, TX, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, [...]
Vystar Completes Acquisition of R3ALM Financial Ecosystem, Targets $120 Million Tokenized Equity Launch
10/08/2026
■ ■ ■ Consideration includes approximately 8,371 shares of Vystar Series B preferred stock Parties intend to jointly manage and develop the R3alm platform R3alm is being developed as a compliance-focused ecosystem [...]
Silo Pharma Granted European Patent Covering Novel PTSD Therapy
10/08/2026
Patent strengthens global IP protection for novel treatment approach designed to prevent stress-induced psychiatric disorders before symptoms develop SARASOTA, FLA., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Silo Pharma (Nasdaq [...]
Women's Health Collective Canada and GreenShield Launch Partnership to Advance Midlife Women's Health Research and Support
10/08/2026
National partnership will help generate critical evidence and improve awareness, education, and support for women navigating the menopause transition and beyond in Canada TORONTO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Women [...]
L’Association canadienne pour l’équité en santé des femmes et GreenShield lancent un partenariat en faveur de la recherche et du soutien dans le domaine de la santé des femmes dans la cinquantaine
10/08/2026
Ce partenariat national aidera à produire des données probantes et à améliorer les ressources de sensibilisation, d’éducation et de soutien pour les femmes vivant la transition vers la ménopause au Canada TORONTO, 10 [...]
Compass Health to purchase Friday Harbor facility from San Juan County, supporting behavioral health care in the islands long-term
10/08/2026
State funding and a decades-long county partnership secure the building's future FRIDAY HARBOR, Wash., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Compass Health is purchasing its Friday Harbor facility located at 520 Spring [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 32 - 2026
10/08/2026
Aggregated presentation by day and by market Weekly report on share repurchases from 04th August to 05th August 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 32 - 2026
10/08/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 4 août au 5 août 2026 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
Helus Pharma to Participate at the Canaccord Genuity 46th Annual Growth Conference in Boston
10/08/2026
CEO Michael Halstead to participate in a fireside chat on Wednesday, August 12 at 12:00 p.m. EDT NEW YORK and TORONTO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or “ [...]

Pages